Raising Capital in Life Sciences in 2022-2023: What Works?
By Greg Curhan
Raising money in the capital markets for a biopharma or life sciences company over the last few years has been quite a roller coaster ride. Funding among U.S. biotech startups reached a record high of $77 billion in 2021 (Crunchbase), as investors were attracted to expanding opportunities in genetics, therapeutics…Read More
Read MoreManaging Performance at Business-to-Consumer (B2C) SaaS Companies
By Eric Mersch
I have written extensively about SaaS business model classification. My articles highlight the key operational differences that drive strategic decision making for SaaS businesses as well as the relevant key performance indicators for management and reporting. This article focuses on the Business-to-Consumer SaaS business model. Specifically, we will discuss their…Read More
Read MoreFive Common CFO Challenges and How to Handle Them
By Stephanie Roberts
Over the course of my career as a CFO, I’ve had the privilege of working with many different CEOs and management teams. I’ve seen several common themes emerge, lessons learned if you will, which have tended to repeat themselves in my experience. (Credit to Sequoia Capital for # 2 and…Read More
Read MoreLeadership Strategies for Retaining Talent in Era of the “Great Resignation”
By Heather Ogan
By now I think we have all heard that “people leave people, not companies”. This concept is more important than ever in the current labor environment of the “great resignation”. Good leadership clearly makes the difference. The Essence of Strategic Leadership Leadership theory is what leaders do, while leadership styles…Read More
Read More